One of the biggest goals of immunotherapy is to reverse T cell exhaustion to boost the immune system’s ability to destroy cancerous cells. Researchers at Sanford Burnham Prebys studying melanoma have found a new way to make this happen.
With the help of a new grant from the U.S. Department of Defense for more than $1.7 million, Associate Professor Charles Spruck, Ph.D., will advance an innovative therapeutic approach for metastatic prostate cancer.
To honor National Minority Health Month, we spoke to Svasti Haricharan about her work, who recently published a paper describing some of the shortfalls of the current research focusing on cancer disparities.
Sanford Burnham Prebys Newsletter
Subscribe to our monthly email newsletter Discoveries.
Connect with us
Follow us on social media for the latest from Sanford Burnham Prebys.